Finch Therapeutics Group logo

Finch Therapeutics Group

Finch Therapeutics Group is a clinical-stage biopharma company established by the founders of OpenBiome.

6

Funding Rounds

$211.3m

Money raised

Overview

Finch Therapeutics Group is a clinical-stage biopharma company established by the founders of OpenBiome.

Funding

Funding series

Funding Series Analysis

The company Finch Therapeutics Group has raised a total of $9.3m in funding over 6 rounds.

Key Insights:

  • Finch Therapeutics Group Venture round, January 21, 2017: $3.7m
  • Finch Therapeutics Group Series A round, December 1, 2016: $5.6m
  • Finch Therapeutics Group, Inc. funding round, May 2019: $23m
  • Finch Therapeutics funding round, March 2018: $36m
  • Finch Therapeutics funding round, August 2019: $53m
  • Finch Therapeutics Group Series D round September 2020: $90m
Finch Therapeutics Group logo
Finch Therapeutics Group Venture round, January 21, 2017 $3.7m
Finch Therapeutics Group logo
Finch Therapeutics Group Series A round, December 1, 2016 $5.6m
Finch Therapeutics Group logo
Finch Therapeutics Group, Inc. funding round, May 2019 $23m
Finch Therapeutics Group logo
Finch Therapeutics funding round, March 2018 $36m
Finch Therapeutics Group logo
Finch Therapeutics funding round, August 2019 $53m
Finch Therapeutics Group logo
Finch Therapeutics Group Series D round September 2020 $90m

Industries

Finch Therapeutics Group is active in the following industries:
  • Biomedical engineering
  • Microbiology
  • Engineering
  • Biology
  • Biotechnology
  • Technology
  • Microbiome
  • Therapeutics